JPRN-jRCTs061180043RecruitingPhase 2
Verification test on pancreatic cancer diagnosis by pancreatic juice cytology using synthetic secretin - S-PJC
Isomoto Hajime0 sites420 target enrollmentStarted: March 8, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Sponsor
- Enrollment
- 420
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 20age old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- •1. Patient provided informed consent at over 20 years old
- •2. Patients suspected of pancreatic cancer by image examination, or patients with IPMN which is classified as high risk stigmata or worrisome features by international consensus guidelines.
Exclusion Criteria
- •1) Patients with hypersensitivity to secretin or other ingredients (excipients: cysteine hydrochloride and Mannitol).
- •2) Patients within 2 weeks after remission from acute pancreatitis or acute exacerbations of chronic pancreatitis.
- •3) A pregnant or lactating woman.
- •4) Patients who received other research drugs or investigational drugs within 3 months prior to the start of administration of the study drug.
- •5) Patients whom the research responsible doctor judged inappropriate.
Investigators
Similar Trials
Recruiting
Phase 2
Verification test on pancreatic cancer diagnosis by pancreatic juice cytology using synthetic secretipancreatic cancerJPRN-UMIN000031492Division of Gastroenterology and Nephrology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University196
Completed
Not Applicable
Diagnosis of pancreatobiliary cancer by measuring the urinary and serum levels of porphyrins after oral administration of 5-aminolevulinic acid.Patients who have suspected pancreatobiliary disease.JPRN-UMIN000018114Kansai Medical University67
Completed
Not Applicable
Developing a diagnostic method for pancreatic cancer at the very early stageIntraductal papillary mucinous neoplasm (IPMN), Pancreatic cancerJPRN-UMIN000017958Osaka City University100
Recruiting
Not Applicable
Biomarker discovery in pancreatobiliary cancer, solid pseudopapillary neoplasm and neuroendocrine tumor, and clinical validation of the candidate biomarkersDiseases of the digestive systemKCT0000436Yonsei University Health System, Severance Hospital40
Recruiting
Not Applicable
Development of a screening test for pancreatic cancer by gastrointestinal endoscopy using synthetic human secretin and a specially-made catheter1. Pancreatic cancer or suspected pancreatic cancer 2. Neither pancreatic cancer nor other cancersPancreatic cancerJPRN-jRCTs051200117Yachida Shinichi150